Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients

被引：1
|
作者：
Coyne, Kathryn [1 ]
Silverman, Paula [2 ]
Liu, James H. [1 ]
机构：
[1] Univ Hosp Cleveland, Univ Hosp MacDonald Womens Hosp, Dept Obstet & Gynecol, Med Ctr, Cleveland, OH 44106 USA
[2] Univ Hosp Seidman, Dept Med, Canc Ctr, Cleveland, OH USA
来源：
CLINICAL BREAST CANCER | 2020年 / 20卷 / 05期
关键词：
Elagolix; GnRH agonist; GnRH antagonist; Ovarian suppression; Premenopausal; PREMENOPAUSAL WOMEN; HUMAN SERUM; TESTOSTERONE; ESTRADIOL; THERAPY;
D O I：
10.1016/j.clbc.2020.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E551 / E554
页数：4
相关论文
共 50 条
  • [41] Clinical outcome of vitrified-warmed blastocysts derived from patients with GnRH antagonist compared GnRH agonist
    Yoon, H.
    Shin, Y.
    Cha, J.
    Kim, H.
    Lee, W.
    Yoon, S.
    Lim, J.
    [J]. HUMAN REPRODUCTION, 2010, 25 : I265 - I265
  • [42] Comparison of two ovarian stimulation protocols, GNRH agonist versus antagonist
    Cardoso, M. F. C. Fonseca
    Pinto, M. P.
    Cardoso, M. F. C. Fonseca
    Pinto, M. P.
    Cardoso, M. F. C. Fonseca
    Sousa, M. S.
    Oliveira, C. O.
    Barros, A. B.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 62 - 62
  • [43] Antitumor effect of GnRH agonist in epithelial ovarian cancer
    Kim, JH
    Park, DC
    Kim, JW
    Choi, YK
    Lew, YO
    Kim, DH
    Jung, JK
    Lim, YA
    Namkoong, SE
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 74 (02) : 170 - 180
  • [44] Comparing clomiphene citrate/ flexible GnRH antagonist vs ultrashort flare GnRH agonist protocols for controlled ovarian stimulation in poor ovarian reserve patients
    Parhar, P.
    Mehta, N.
    Rao, D.
    Chaitanya, K.
    [J]. HUMAN REPRODUCTION, 2023, 38
  • [45] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    Filho, J. S. Cunha
    Terres, L. F.
    Holanda, F.
    Freitas, F.
    Glitz, C.
    Genro, V. K.
    Arbo, E.
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (08) : 326 - 330
  • [46] GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome
    Rabinson, Jacob
    Meltcer, Simion
    Zohav, Efrairn
    Gemer, Ofer
    Anteby, Eyal Y.
    Orvieto, Raoul
    [J]. FERTILITY AND STERILITY, 2008, 89 (02) : 472 - 474
  • [47] Preservation of ovarian follicle by concomitant administration of GnRH agonist or GnRH antagonist during cyclophosphamide or paclitaxel chemotherapy in mice
    Yang, H. S.
    Kim, M. W.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 364 - 364
  • [48] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    J. S. Cunha Filho
    L. F. Terres
    F. Holanda
    F. Freitas
    C. Glitz
    V. K. Genro
    E. Arbo
    [J]. Journal of Assisted Reproduction and Genetics, 2007, 24 : 326 - 330
  • [49] Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
    Kalafat, Erkan
    Turkgeldi, Engin
    Yildiz, Sule
    Dizdar, Merve
    Keles, Ipek
    Ata, Baris
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [50] GnRH agonist versus GnRH antagonist during controlled ovarian hyperstimulation (COH): Is there an effect on oocyte maturity and aneuploidy
    Ghadir, S
    Sarajari, S
    Kumar, A
    Li, M
    Hill, D
    Danzer, H
    Surrey, M
    [J]. FERTILITY AND STERILITY, 2005, 83 : S15 - S15
12345